• COVID-19 vaccine confidence rapid community assessment guide : a guide to help you understand your community’s needs regarding COVID-19 vaccines in three weeks Cite CITE Title : COVID-19 vaccine confidence rapid community assessment guide : a guide to help you understand your community’s needs regarding COVID-19 vaccines in three weeks Corporate Authors(s) : Centers for Disease Control and Prevention (U.S.) Published Date : October 2021 Series : Vaccinate with confidence URL : https://stacks.cdc.gov/view/cdc/113701 Centers for Disease Control and Prevention (U.S.) (2021). COVID-19 vaccine confidence rapid community assessment guide : a guide to help you understand your community’s needs regarding COVID-19 vaccines in three weeks. Centers for Disease Control and Prevention (U.S.) "COVID-19 vaccine confidence rapid community assessment guide : a guide to help you understand your community’s needs regarding COVID-19 vaccines in three weeks" (2021) Centers for Disease Control and Prevention (U.S.) "COVID-19 vaccine confidence rapid community assessment guide : a guide to help you understand your community’s needs regarding COVID-19 vaccines in three weeks" , 2021 Export RIS Citation Information. Copy Copied Save Generic APA MLA Chicago RIS [PDF - 2.75 MB] Corporate Authors: Centers for Disease Control and Prevention (U.S.) October 2021 | Vaccinate with confidence Description: This rapid community assessment (RCA) guide is for staff of state, territorial, local, and tribal health departments involved in various aspects of CO... File Type: [PDF - 2.75 MB] File Type: [PDF - 2.75 MB] Addendum : Considerations for conducting rapid community assessment in adolescent populations and digital contexts Cite CITE Title : Addendum : Considerations for conducting rapid community assessment in adolescent populations and digital contexts Corporate Authors(s) : Centers for Disease Control and Prevention (U.S.) Published Date : November 2021 Series : Vaccinate with confidence URL : https://stacks.cdc.gov/view/cdc/113699 Centers for Disease Control and Prevention (U.S.) (2021). Addendum : Considerations for conducting rapid community assessment in adolescent populations and digital contexts. Centers for Disease Control and Prevention (U.S.) "Addendum : Considerations for conducting rapid community assessment in adolescent populations and digital contexts" (2021) Centers for Disease Control and Prevention (U.S.) "Addendum : Considerations for conducting rapid community assessment in adolescent populations and digital contexts" , 2021 Export RIS Citation Information. Copy Copied Save Generic APA MLA Chicago RIS [PDF - 898.96 KB] Corporate Authors: Centers for Disease Control and Prevention (U.S.) November 2021 | Vaccinate with confidence Description: This document outlines considerations and guidelines for working with adolescent populations (12–17 years old) and gathering information from digita... File Type: [PDF - 898.96 KB] File Type: [PDF - 898.96 KB] Di(2-etilhexil) ftalato (DEHP) Cite CITE Title : Di(2-etilhexil) ftalato (DEHP) Corporate Authors(s) : United States. Agency for Toxic Substances and Disease Registry. Published Date : Septiembre 2002 Series : ToxFAQs URL : https://stacks.cdc.gov/view/cdc/113702 United States. Agency for Toxic Substances and Disease Registry. (2002). Di(2-etilhexil) ftalato (DEHP). United States. Agency for Toxic Substances and Disease Registry. "Di(2-etilhexil) ftalato (DEHP)" (2002) United States. Agency for Toxic Substances and Disease Registry. "Di(2-etilhexil) ftalato (DEHP)" , 2002 Export RIS Citation Information. Copy Copied Save Generic APA MLA Chicago RIS [PDF - 269.77 KB] Corporate Authors: United States. Agency for Toxic Substances and Disease Registry. Septiembre 2002 | ToxFAQs Description: Esta hoja informativa contesta las preguntas más frecuentes acerca de los efectos del di(2-etilhexil)ftalato (DEHP) sobre la salud. Para más infor... File Type: [PDF - 269.77 KB] File Type: [PDF - 269.77 KB] Addendum: Considerations for conducting rapid community assessment in tribal communities Cite CITE Title : Addendum: Considerations for conducting rapid community assessment in tribal communities Corporate Authors(s) : Centers for Disease Control and Prevention (U.S.) Published Date : November 2021 Series : Vaccinate with confidence URL : https://stacks.cdc.gov/view/cdc/113700 Centers for Disease Control and Prevention (U.S.) (2021). Addendum: Considerations for conducting rapid community assessment in tribal communities. Centers for Disease Control and Prevention (U.S.) "Addendum: Considerations for conducting rapid community assessment in tribal communities" (2021) Centers for Disease Control and Prevention (U.S.) "Addendum: Considerations for conducting rapid community assessment in tribal communities" , 2021 Export RIS Citation Information. Copy Copied Save Generic APA MLA Chicago RIS [PDF - 990.82 KB] Corporate Authors: Centers for Disease Control and Prevention (U.S.) November 2021 | Vaccinate with confidence Description: This document outlines considerations and guidelines for working with Tribal Communities as part of a Rapid Community Assessment (RCA).CDC-RCA-Guide-T... File Type: [PDF - 990.82 KB] File Type: [PDF - 990.82 KB] Effectiveness of a third dose of mRNA vaccines against COVID-19–associated emergency department and urgent care encounters and hospitalizations among adults during periods of Delta and Omicron Variants predominance — VISION Network, 10 States, August 2021–January 2022 Cite CITE Title : Effectiveness of a third dose of mRNA vaccines against COVID-19–associated emergency department and urgent care encounters and hospitalizations among adults during periods of Delta and Omicron Variants predominance — VISION Network, 10 States, August 2021–January 2022 Personal Author(s) : Thompson, Mark G.;Natarajan, Karthik;Irving, Stephanie A.;Rowley, Elizabeth A.;Griggs, Eric P.;Gaglani, Manjusha;Klein, Nicola P.;Grannis, Shaun J.;DeSilva, Malini B.;Stenehjem, Edward;Reese, Sarah E.;Dickerson, Monica;Naleway, Allison L.;Han, Jungmi;Konatham, Deepika;McEvoy, Charlene;Rao, Suchitra;Dixon, Brian E.;Dascomb, Kristin;Lewis, Ned;Levy, Matthew E.;Patel, Palak;Liao, I-Chia;Kharbanda, Anupam B.;Barron, Michelle A.;Fadel, William F.;Grisel, Nancy;Goddard, Kristin;Yang, Duck-Hye;Wondimu, Mehiret H.;Murthy, Kempapura;Valvi, Nimish R.;Arndorfer, Julie;Fireman, Bruce;Dunne, Margaret M.;Embi, Peter;Azziz-Baumgartner, Eduardo;Zerbo, Ousseny;Bozio, Catherine H.;Reynolds, Sue;Ferdinands, Jill;Williams, Jeremiah;Link-Gelles, Ruth;Schrag, Stephanie J.;Verani, Jennifer R.;Ball, Sarah;Ong, Toan C.; Corporate Authors(s) : CDC COVID-19 Response Team.;Columbia University. Department of Biomedical Informatics.;New York Presbyterian Hospital.;Center for Health Research (Kaiser-Permanente Medical Care Program. Northwest Region);Texas A&M University College of Medicine. Baylor Scott & White Health.;Kaiser Permanente Vaccine Study Center.;Regenstrief Institute for Health Care‏. Center for Biomedical Informatics.;Indiana University. Richard M. Fairbanks School of Public Health.;HealthPartners Institute.;Intermountain Healthcare (Utah). Division of Infectious Diseases and Clinical Epidemiology.;University of Colorado Anschutz Medical Campus. Department of Medicine.;Indiana University. Fairbanks School of Public Health;Children’s Minnesota (Minneapolis, Minnesota;Vanderbilt University.;VISION Network.; Published Date : January 21, 2022 Series : MMWR. Morbidity and Mortality Weekly Report ; v. 71, early release, January 21, 2022 URL : https://stacks.cdc.gov/view/cdc/113718 Thompson, Mark G. et al. (2022). Effectiveness of a third dose of mRNA vaccines against COVID-19–associated emergency department and urgent care encounters and hospitalizations among adults during periods of Delta and Omicron Variants predominance — VISION Network, 10 States, August 2021–January 2022. 71 Thompson, Mark G. et al. "Effectiveness of a third dose of mRNA vaccines against COVID-19–associated emergency department and urgent care encounters and hospitalizations among adults during periods of Delta and Omicron Variants predominance — VISION Network, 10 States, August 2021–January 2022" 71 (2022) Thompson, Mark G. et al. "Effectiveness of a third dose of mRNA vaccines against COVID-19–associated emergency department and urgent care encounters and hospitalizations among adults during periods of Delta and Omicron Variants predominance — VISION Network, 10 States, August 2021–January 2022" vol. 71, 2022 Export RIS Citation Information. Copy Copied Save Generic APA MLA Chicago RIS [PDF - 417.21 KB] Personal Author: Thompson, Mark G. ; Natarajan, Karthik ... January 21, 2022 | MMWR. Morbidity and Mortality Weekly Report ; v. 71, early release, January 21, 2022 Description: What is already known about this topic? COVID-19 mRNA vaccine effectiveness (VE) in preventing COVID-19 might decline because of waning of vaccine-ind... File Type: [PDF - 417.21 KB] File Type: [PDF - 417.21 KB] COVID-19 incidence and death rates among unvaccinated and fully vaccinated adults with and without booster doses during periods of Delta and Omicron Variants emergence — 25 U.S. jurisdictions, April 4–December 25, 2021 Cite CITE Title : COVID-19 incidence and death rates among unvaccinated and fully vaccinated adults with and without booster doses during periods of Delta and Omicron Variants emergence — 25 U.S. jurisdictions, April 4–December 25, 2021 Personal Author(s) : Johnson, Amelia G.;Amin, Avnika B.;Ali, Akilah R.;Hoots, Brooke;Cadwell, Betsy L.;Arora, Shivani;Avoundjian, Tigran;Awofeso, Abiola O.;Barnes, Jason;Bayoumi, Nagla S.;Busen, Katherine;Chang, Carolyn;Cima, Mike;Crockett, Molly;Cronquist, Alicia;Davidson, Sherri;Davis, Elizabeth;Delgadill0, Janelle;Dorabawila, Vajeera;Drenzek, Cherie;Eisenstein, Leah;Fast, Hannah E.;Gent, Ashley;Hand, Julie;Hoefer, Dina;Holtzman, Corinne;Jara, Amanda;Jones, Amanda;Kamal-Ahmed, Ishrat;Kangas, Sarah;Kanishka, FNU;Kaur, Ramandeep;Khan, Saadiah;King, Justice;Kirkendall, Samantha;Klioueva, Anna;Kocharian, Anna;Kwon, Frances Y.;Logan, Jacqueline;Lyons, B. Casey;Lyons, Shelby;May, Andrea;McCormick, Donald;Mendoza, Erica;Milroy, Lauren;O’Donnell, Allison;Pike, Melissa;Pogosjans, Sargis;Saupe, Amy;Sell, Jessica;Smith, Elizabeth;Sosin, Daniel M.;Stanislawski, Emma;Steele, Molly K.;Stephenson, Meagan;Stout, Allen;Strand, Kyle;Tilakaratne, Buddhi P.;Turner, Kathryn;Vest, Hailey;Warner, Sydni;Wiedeman, Caleb;Zaldivar, Allison;Silk, Benjamin J.;Scobie, Heather M.; Corporate Authors(s) : CDC COVID-19 Emergency Response Team. Epidemiology Task Force.;Rhode Island. Department of Health.;Seattle & King County. Of Dept. Public Health.;District of Columbia Department of Health;Utah. Department of Health.;New Jersey. Department of Health.;Michigan. Department of Health and Human Services.;New York (N.Y.). Department of Health and Mental Hygiene.;Arkansas. Department of Health.;Massachusetts. Department of Public Health.;Colorado. Department of Public Health and Environment.;Alabama. Department of Public Health.;New Mexico. Department of Health.;New York. State Department of Health.;Georgia. Department of Public Health.;Florida. Department of Health.;COVID-19 Response Team. Vaccine Task Force.;Louisiana. Department of Health.;Minnesota. Department of Health.;Center for Surveillance, Epidemiology, and Laboratory Services (U.S.);Nebraska. Department of Health and Human Services.;Wisconsin. Department of Health Services.;Idaho. Department of Health and Welfare.;Texas. Department of State Health Services.;Tennessee. Department of Health.;CDD COVID-19 Emergency Response Team. Data Analytics and Visualization Task Force.;Kansas. Department of Health and Environment.;Indiana. Department of Health.; Published Date : January 21, 2022 Series : MMWR. Morbidity and Mortality Weekly Report ; v. 71, early release, January 21, 2022 URL : https://stacks.cdc.gov/view/cdc/113717 Johnson, Amelia G. et al. (2022). COVID-19 incidence and death rates among unvaccinated and fully vaccinated adults with and without booster doses during periods of Delta and Omicron Variants emergence — 25 U.S. jurisdictions, April 4–December 25, 2021. 71 Johnson, Amelia G. et al. "COVID-19 incidence and death rates among unvaccinated and fully vaccinated adults with and without booster doses during periods of Delta and Omicron Variants emergence — 25 U.S. jurisdictions, April 4–December 25, 2021" 71 (2022) Johnson, Amelia G. et al. "COVID-19 incidence and death rates among unvaccinated and fully vaccinated adults with and without booster doses during periods of Delta and Omicron Variants emergence — 25 U.S. jurisdictions, April 4–December 25, 2021" vol. 71, 2022 Export RIS Citation Information. Copy Copied Save Generic APA MLA Chicago RIS [PDF - 493.78 KB] Personal Author: Johnson, Amelia G. ; Amin, Avnika B. ... January 21, 2022 | MMWR. Morbidity and Mortality Weekly Report ; v. 71, early release, January 21, 2022 Description: What is already known about this topic? Although COVID-19 vaccine effectiveness decreased with emergence of the Delta Variants and waning of vaccine-i... File Type: [PDF - 493.78 KB] File Type: [PDF - 493.78 KB]

More +